IL6 and acute lymphoblastic leukemia: As shown in Table 2, the reduction in IL-6 levels following PE treatment in four NHL patients (average 80%) was comparable to that observed in ALL patients (average 75%), while the future studies might need to expand the sample size of non-ALL cases to further validate the generalizability of PE.